Cécile Laurent
Cécile Laurent
Potvrđena adresa e-pošte na
Establishment and characterization of a panel of human uveal melanoma xenografts derived from primary and/or metastatic tumors
F Némati, X Sastre-Garau, C Laurent, J Couturier, P Mariani, L Desjardins, ...
Clinical cancer research 16 (8), 2352-2362, 2010
High PTP4A3 phosphatase expression correlates with metastatic risk in uveal melanoma patients
C Laurent, F Valet, N Planque, L Silveri, S Maacha, O Anezo, P Hupe, ...
Cancer research 71 (3), 666-674, 2011
Luminal progenitors restrict their lineage potential during mammary gland development
V Rodilla, A Dasti, M Huyghe, D Lafkas, C Laurent, F Reyal, S Fre
PLoS biology 13 (2), e1002069, 2015
Stromal lymphocyte infiltration after neoadjuvant chemotherapy is associated with aggressive residual disease and lower disease-free survival in HER2-positive …
AS Hamy, JY Pierga, A Sabaila, E Laas, H Bonsang-Kitzis, C Laurent, ...
Annals of Oncology 28 (9), 2233-2240, 2017
EMA-AR package for Easy Microarray data analysis
N Servant, E Gravier, P Gestraud, C Laurent, C Paccard, A Biton, I Brito, ...
BMC research notes 3 (1), 277, 2010
Patient‐derived xenografts recapitulate molecular features of human uveal melanomas
C Laurent, D Gentien, S Piperno-Neumann, F Némati, A Nicolas, ...
Molecular oncology 7 (3), 625-636, 2013
Biological network-driven gene selection identifies a stromal immune module as a key determinant of triple-negative breast carcinoma prognosis
H Bonsang-Kitzis, B Sadacca, AS Hamy-Petit, M Moarii, A Pinheiro, ...
Oncoimmunology 5 (1), e1061176, 2016
Protein Tyrosine Phosphatase 4A3 (PTP4A3) Promotes Human Uveal Melanoma Aggressiveness Through Membrane Accumulation of Matrix Metalloproteinase 14 (MMP14) PTP4A3 and MMP14 …
S Maacha, O Anezo, M Foy, G Liot, L Mery, C Laurent, X Sastre-Garau, ...
Investigative ophthalmology & visual science 57 (4), 1982-1990, 2016
A stromal immune module correlated with the response to neoadjuvant chemotherapy, prognosis and lymphocyte infiltration in HER2-positive breast carcinoma is inversely …
AS Hamy, H Bonsang-Kitzis, M Lae, M Moarii, B Sadacca, A Pinheiro, ...
PloS one 11 (12), e0167397, 2016
Protein tyrosine phosphatase 4A3 (PTP4A3) is required for Xenopus laevis cranial neural crest migration in vivo
S Maacha, N Planque, C Laurent, C Pegoraro, O Anezo, F Maczkowiak, ...
PloS one 8 (12), e84717, 2013
PTP4A3, a Signal Molecule Deregulated in Uveal Melanoma Metastasis
C Laurent, J Couturier, X Sastre-Garau, L Desjardins, E Barillot, ...
Signal Transduction in Cancer Metastasis, 255-263, 2010
Efficacy of capecitabine in chemoresistant PDX established from triple-negative breast cancers with residual disease after neoadjuvant chemotherapy
E Marangoni, C Laurent, F Coussy, R El Botty, L de Plater, F Assayag, ...
Cancer Research 77 (13 Supplement), 3859-3859, 2017
Package ‘EMA’
N Servant, E Gravier, P Gestraud, C Laurent, MP Gestraud
Identification of a predictive and prognostic immune stromal module associated with lymphocytic infiltrate in HER2-positive breast cancers Abstracts
AS Hamy-Petit, H Bonsang-Kitzis, M Lae, M Moarii, B Sadacca, ...
BULLETIN DU CANCER 103 (6), S110-S111, 2016
Potential targets of PTP4A3 involved in uveal melanoma migration
G Liot, O Anezo, C Laurent, S Maacha, N Planque, S Saule
Cancer Research 74 (19 Supplement), 4063-4063, 2014
Abstract A9: Establishment and characterization of residual breast cancer patient-derived xenografts resistant to neo-adjuvant therapy.
E Marangoni, D Labiod, F Assayag, R El Botty, R Hatem, S Richon, ...
Molecular Cancer Therapeutics 12 (11 Supplement), A9-A9, 2013
Abstract LB-263: Identification of gene-expression modifications related to the tumor engraftment in patient-derived xenograft models of solid tumors.
C Laurent, E Marangoni, P Hupé, F Némati, N Cassoux, D Gentien, ...
Cancer Research 73 (8 Supplement), LB-263-LB-263, 2013
Abstract B16: Genomic, genetic, and gene expression profile characterization of a panel of primary human uveal melanoma xenografts.
C Laurent, F Nemati, D Gentien, L Desjardins, P Mariani, A Rapinat, ...
Molecular Cancer Therapeutics 10 (11 Supplement), B16-B16, 2011
Sustav trenutno ne može provesti ovu radnju. Pokušajte ponovo kasnije.
Članci 1–18